ARTICLE | Company News
Adocia, Eli Lilly deal
December 22, 2014 8:00 AM UTC
Adocia granted Eli Lilly exclusive, worldwide rights to develop, manufacture and commercialize BioChaperone Lispro for Type I and Type II diabetes. Adocia will receive $50 million up front and is elig...